+3 | The top 3 med-tech stories for December 10, 2012

December 10, 2012 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

3. Sanofi's last on the list to buy Bayer's glucose devices

French healthcare giant Sanofi is the last buyer still in the running to acquire German Bayer's blood glucose management devices, a deal that may be worth more than $1.5 billion, sources say.

Read more

Sign up to get our free newsletters delivered straight to your inbox